OUTCOMES AFTER TRANSTHORACIC, PERIPHERAL VASCULAR AND TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION: A PROPENSITY ANALYSIS FROM FRANCE TAVI REGISTRY

Methods In the FRANCE TAVI registry that includes all patients undergoing TAVR in France, we compared the 30-days outcomes of TAVR performed through peripheral vascular access, transthoracic access, and transfemoral access, with a propensity adjustment based on 23 preprocedural variables, exclusive...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A990-A990
Main Authors: Beurtheret, Sylvain, Karam, Nicole, Resseguier, Noemie, Houel, Remi, Com, Olivier, Gelisse, Richard, Bille, Jacques, Joly, Patrick, Barra, Nicolas, Commeau, Philippe, Armero, Sebastien, Pankert, Mathieu, Seitz, Julien, Eltchaninoff, Helene, Leprince, Pascal, Le Breton, Herve
Format: Article
Language:English
Subjects:
Aortic valve
Cardiology
Catheters
Implantation
Mortality
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods In the FRANCE TAVI registry that includes all patients undergoing TAVR in France, we compared the 30-days outcomes of TAVR performed through peripheral vascular access, transthoracic access, and transfemoral access, with a propensity adjustment based on 23 preprocedural variables, exclusive of vascular access anatomy. Through a propensity score analysis we compared 6897/10598 transfemoral access patients, 581/820 peripheral vascular access patients, and 767/1243 transthoracic access patients. 30-days mortality was significantly higher in the transthoracic group (OR = 2.84 [2.14 - 3.78], P< 0.001) but not in the peripheral vascular group (OR = 1.11 [0.71-1.76], P=0.649).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)31531-6